
COVID-19 update: Exosomes for ARDS?
Within 24 hours of exosome treatment, the COVID patient with ARDS showed decreased requirement for oxygen and pressure and within 5 days, he was being extubated.
Within 24 hours of exosome treatment, the COVID patient with ARDS showed decreased requirement for oxygen and pressure and within 5 days, he was being extubated.
Yes we battle Coronaviruses every year but this strain appears to be a recent zoonosis (disease from animals) that has certainly taken a huge economic toll.
If your mind is free, I challenge you to read the above articles by the three public health experts and ask yourself whether they seem credible.
we are witnessing the emergence of a new religious cult and you can’t argue religion when the existence of the supernatural delusions are held as axiomatic
Everybody calm down. The death rate is not high, this is not a new threat, it still affects older people with immune aging, we will likely have herd immunity making it less severe each year,
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness